Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $21,156,000 | $20,993,000 | $22,232,000 | $19,687,000 |
| % Growth | 0.8% | -5.6% | 12.9% | – |
| Cost of Goods Sold | $8,671,000 | $8,600,000 | $8,527,000 | $7,351,000 |
| Gross Profit | $12,485,000 | $12,393,000 | $13,705,000 | $12,336,000 |
| % Margin | 59% | 59% | 61.6% | 62.7% |
| R&D Expenses | $2,279,000 | $2,445,000 | $2,521,000 | $2,408,000 |
| G&A Expenses | $1,392,000 | $1,392,000 | $1,306,000 | $1,241,000 |
| SG&A Expenses | $5,360,000 | $5,329,000 | $5,403,000 | $4,955,000 |
| Sales & Mktg Exp. | $3,968,000 | $3,914,000 | $4,097,000 | $3,714,000 |
| Other Operating Expenses | $1,201,000 | $1,010,000 | $1,029,000 | $777,000 |
| Operating Expenses | $8,840,000 | $8,784,000 | $8,953,000 | $8,140,000 |
| Operating Income | $3,645,000 | $3,609,000 | $4,474,000 | $4,179,000 |
| % Margin | 17.2% | 17.2% | 20.1% | 21.2% |
| Other Income/Exp. Net | -$109,000 | -$125,000 | -$187,000 | -$255,000 |
| Pre-Tax Income | $3,536,000 | $3,484,000 | $4,287,000 | $3,924,000 |
| Tax Expense | $751,000 | $650,000 | $948,000 | $859,000 |
| Net Income | $2,777,000 | $2,824,000 | $3,326,000 | $3,055,000 |
| % Margin | 13.1% | 13.5% | 15% | 15.5% |
| EPS | 1.28 | 1.3 | 1.53 | 1.41 |
| % Growth | -1.5% | -15% | 8.5% | – |
| EPS Diluted | 1.28 | 1.3 | 1.53 | 1.41 |
| Weighted Avg Shares Out | 2,173,889 | 2,175,655 | 2,173,889 | 2,173,889 |
| Weighted Avg Shares Out Dil | 2,173,889 | 2,173,889 | 2,173,889 | 2,173,889 |
| Supplemental Information | – | – | – | – |
| Interest Income | $164,000 | $121,000 | $72,517 | $54,371 |
| Interest Expense | $292,000 | $272,000 | $203,889 | $288,403 |
| Depreciation & Amortization | $2,134,000 | $1,880,000 | $1,798,000 | $1,712,000 |
| EBITDA | $5,962,000 | $5,685,000 | $6,279,000 | $5,880,000 |
| % Margin | 28.2% | 27.1% | 28.2% | 29.9% |